Westrock Coffee Company WEST 深 沪
等待开盘 04-01 09:30:00 美东时间
4.25
+0.200
+4.94%
华盛通- 最 高4.25
- 今 开4.07
- 成交量 25.34万股
- 最 低 3.9901
- 昨 收 4.05
- 总市值 4.12亿
- 52周最高 7.92
- 市盈率 静 --
- 换手率 0.26%
- 52周最低 3.59
- 委 比 -85.05%
- 总股本 9682.49万
- 历史最高 14.71
- 量 比 1.00
- 振 幅 6.42%
- 历史最低 3.59
- 每 手 1
- 风险率 1.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Westrock Coffee Q4 Earnings Assessment
Westrock Coffee (NASDAQ:WEST) released its Q4 earnings on Tuesday, March 10, 20...
03-11 04:08
Earnings Scheduled For March 10, 2026
Companies Reporting Before The Bell • Ultralife (NASDAQ:ULBI) is likely to repo...
03-10 19:11
Westrock Coffee Company to Report Fourth Quarter 2025 Financial Results on March 10th, 2026
Westrock Coffee Company will report its fourth quarter 2025 results on March 10, 2026, after market close, followed by a live earnings conference call at 4:30 p.m. ET. Participants can register for the call via the provided link, and the webcast will be available on the Company’s Investor Relations website. The company, which provides coffee, tea, and related solutions to various industries globally, sources coffee and tea from 35 origin countrie...
02-17 21:05
Westrock Coffee Company Achieves 100% Responsibly Sourced Commitment
Company celebrates milestone achievement and advances long-term supply resilience LITTLE ROCK, Ark., Feb. 16, 2026 /PRNewswire/ -- Westrock Coffee Company (Nasdaq: WEST) ("Westrock Coffee" o...
02-16 21:00
Longleaf Partners Small-Cap Fund reports 2025 results
Longleaf Partners Small-Cap Fund (LLSCX) reported a 7.56% total return, compared with 12.81% for the Russell 2000 and 17.15% for the Russell 3000. During 2025, the fund added new positions in Shenando...
01-21 00:13
Westrock Coffee CEO Scott T. Ford Reports Acquisition of Common Shares
Scott T. Ford, Chief Executive Officer of Westrock Coffee Company, reported the acquisition of common shares of Westrock Coffee Company. The full filing can be accessed through the link below. Disclai...
2025-12-12 05:24
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
电话会总结 ｜ Westrock Coffee(WEST)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Westrock Coffee业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 合并净销售额同比增长61%，主要受益于销量增长和原材料成本上涨的传导 - 饮料解决方案部门净销售额同比增长60% - 可持续采购与追溯(SS&T)部门净销售额同比增长62% **盈利能力：** - 合并调整后EBITDA达到2,320万美元，同比增长125% - 合并分部调整后EBITDA达到2,620万美元，环比增长14%，同比增长84% - 饮料解决方案部门调整后EBITDA为2,040万美元，同比增长74% - SS&T部门调整
2025-11-07 12:16
Westrock Coffee shares are trading higher after the company reported better-than-expected Q3 sales results.
Westrock Coffee shares are trading higher after the company reported better-tha...
2025-11-07 06:01
